MAPK8 and colorectal cancer: Our study identified that MALAT1 promotes colorectal cancer oxaliplatin resistance by reducing the miR-200s expression, and ZJW may reverse chemoresistance by inhibiting the expression of MALAT1 and regulating the miR-200s/JNK pathway.